IL-13, His, Cynomolgus
| ¥3500 | |
| Z04826-100 | |
|
|
|
|
|
|
|
|
|
| ¥3500 | |
| Z04826-100 | |
|
|
|
|
|
|
|
|
|
| Species | Cynomolgus | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 13.59 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 30-45 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Loaded IL-13, His, Cynomolgus, His Tag on Anti-His-Biosensor can bind Human IL-13Ra2, hFc Tag with an affinity constant of 0.14 µM as determined in BLI assay (Gator® Prime). »
Immobilized IL-13, His, Cynomolgus, His Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human IL-13Ra2, hFc Tag with the EC50 of 75.8ng/ml determined by ELISA. »
The purity of IL-13, His, Cynomolgus is greater than 95% as determined by SEC-HPLC. »
IL-13, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
IL-13, His, Cynomolgus, His Tag immobilized on CM5 Chip can bind Cynomolgus IL-13, His Tag with an affinity constant of 21.16 nM as determined in SPR assay (Biacore T200). »
| Target Background | Interleukin-13 (IL-13) is a monomeric 17 kDa immunoregulatory cytokine that plays a key role in the pathogenesis of allergy, cancer, and tissue fibrosis. It is secreted by several helper T cell subsets, NK cells, mast cells, eosinophils, basophils, and visceral smooth muscle cells. Inhibits inflammatory cytokine production. Synergizes with IL2 in regulating interferon-gamma synthesis. May be critical in regulating inflammatory and immune responses. Positively regulates IL31RA expression in macrophages. |
| Synonyms | interleukin 13; NC30; P600; ALRH; BHR1; MGC116786; MGC116788; MGC116789 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.